Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults
NCT00698893
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Simplex
Interventions
BIOLOGICAL:
Herpes simplex candidate (gD) vaccine GSK208141
Sponsor
GlaxoSmithKline